Company announces multi-institution collaboration to advance ALS research
Verge Genomics, a drug discovery company utilizing genomic data for neuroscience therapeutics, announced today that it is has established a multi-institution industry-academic collaboration with four top universities focused on accelerating the translation of preclinical models of amyotrophic lateral sclerosis … Read More »